Jan 13 (Reuters) - The U.S Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for a type of rare genetic disease in children, Fortress said on Tuesday.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Devika Syamnath)
